Serum Institute Receives Approval To Launch Covovax Trials On Children Aged 7-11
New Deal Between Serum Institute Of India And Biocon Covers Vaccines, Other Biotech Products
Vaccinomics 1.0: There Is No Free Lunch Even When It Comes To Life-Savers
Serum Institute CEO Adar Poonawalla Takes Covid Vaccine To 'Endorse' Its Safety And Efficacy
